Skip to main content

. 1960 Sep 24;2(5203):913–915. doi: 10.1136/bmj.2.5203.913

Preliminary Observations on Management of Diabetes with “Stabinol”

M F Healy, J D Arneaud

PMCID: PMC2098141 PMID: 14400418

913

Images in this article

Fig. 1
on p.915

Fig. 2
on p.915

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DAVIS T. W., KERR R. B., BOGOCH A. Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug. Can Med Assoc J. 1959 Jul 15;81(2):101–107. [PMC free article] [PubMed] [Google Scholar]
KRALL L. P., CAMERINI-DAVALOS R. Clinical trials with DBI, a new nonsulfonylurea oral hypoglycemic agent. AMA Arch Intern Med. 1958 Jul;102(1):25–31. doi: 10.1001/archinte.1958.00260190027004. [DOI] [PubMed] [Google Scholar]
MEHNERT H., CAMERINI-DAVALOS R., MARBLE A. Results of long-term use of tolbutamide (orinase) in diabetes mellitus. J Am Med Assoc. 1958 Jun 14;167(7):818–827. doi: 10.1001/jama.1958.02990240018004. [DOI] [PubMed] [Google Scholar]
McKENDRY J. B., KUWAYTI K., SAGLE L. A. Experience with tolbutamide (orinase in the management of 100 cases of diabetes. Can Med Assoc J. 1957 Sep 1;77(5):429–438. [PMC free article] [PubMed] [Google Scholar]
TULLOCH J. A. Experience in Jamaica with the oral treatment of diabetes. West Indian Med J. 1957 Mar;6(1):43–54. [PubMed] [Google Scholar]

ACTIONS

RESOURCES